Octagon Therapeutics has filed a notice of an exempt offering of securities to raise $12,410,030.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Octagon Therapeutics is raising up to $12,410,030.00 in new funding. Sources indicate that as part of senior management President and Chief Operating Officer, Isaac Stoner…